MedNewsWeek

🎙️ Advancing Cancer Innovation: Early Detection, Drug Discovery & Precision Medicine Join MedNews Week for an insightful conversation with Dr. Shernan Holtan, Chief of Hematology and Cell Therapy at Allina Health and an internationally recognized leader in stem cell transplantation, cellular therapy, and GVHD research. A pioneering physician-scientist whose contributions have helped shape modern transplantation practices and advance innovative cancer therapies, Dr. Holtan brings a unique perspective on translating scientific discoveries into meaningful improvements in patient care. 🔬 Explore the future of early cancer detection, drug discovery, and precision medicine, and the innovations transforming oncology. ▶️ Watch the full episode exclusively on OncoDaily TV: youtube.com/watch?v=B9ox7PRi… #MedNewsWeek #ShernanHoltan #PrecisionMedicine #CancerResearch #DrugDiscovery #CellTherapy #Oncology #WomenInMedicine

THE FUTURE OF CANCER CARE: INNOVATION, LEADERSHIP & PRECISION MEDICINE What does it take to transform cancer care, advance early detection, and bring cutting-edge innovation to the patients who need it most? At MedNews Week, we were honored to welcome Dr. Douglas Flora, MD, LSSBB, a nationally recognized oncology leader, innovator, and President of the Association of Cancer Care Centers (ACCC), for a special conversation on: 🔬 Early Cancer Detection, Drug Discovery & Precision Medicine With over two decades of experience transforming oncology care, Dr. Flora has helped shape nationally recognized cancer screening programs, expand access to clinical trials, and champion the responsible integration of artificial intelligence into clinical oncology. As a physician executive, researcher, author, and thought leader, his work exemplifies how visionary leadership and emerging technologies can converge to improve patient outcomes. Our conversation explored the future of cancer detection, AI-driven innovation, precision oncology, and the challenges of translating scientific advances into meaningful, equitable patient care. A heartfelt thank you to Dr. Flora for sharing his insights, leadership, and commitment to advancing cancer care and inspiring the next generation of innovators. At MedNews Week, we believe the future of medicine is built through collaboration, innovation, and making knowledge accessible to all. 🌎 🎥 Catch this featured MedNews Week conversation on OncoDaily TV: youtube.com/watch?v=27o9ewea… #MedNewsWeek #DouglasFlora #Oncology #PrecisionMedicine #ArtificialIntelligence #CancerResearch #HealthcareLeadership #EarlyCancerDetection #MedicalInnovation

At MedNews Week, we were honored to welcome Dr. Douglas Flora, MD, LSSBB, a nationally recognized oncology leader, innovator, and President of the Association of Cancer Care Centers (ACCC), for a special conversation on: 🔬 Early Cancer Detection, Drug Discovery & Precision Medicine 🎥 Catch this featured MedNews Week conversation on Oncodaily TV: youtube.com/watch?v=27o9ewea…

How 2024's Breakthroughs Are Redefining Glioma Management teapaw.org/i/broadcasts/1kJzDPenl…

Honored to have been invited as a Distinguished Keynote Speaker at the 2026 World Aging & Longevity Conference (WALC) in Tokyo, Japan! 🇯🇵 It was a tremendous privilege to join an international community of scientists, clinicians, and innovators dedicated to advancing medicine and shaping the future of human health. During my keynote, “Bridging the Trial-Matching Gap in Cell & Gene Therapy with Artificial Intelligence: Real-World Validation of an mCODE-Aligned GPT-4o Platform,” I had the opportunity to share our research exploring how AI can help overcome longstanding barriers to clinical trial access, particularly in the rapidly evolving field of cellular and gene therapies. Innovation is only meaningful when it reaches the patients who need it most. As we enter a new era of precision medicine, our responsibility extends beyond developing powerful technologies. We must ensure that these innovations are clinically meaningful, rigorously validated, and accessible to patients regardless of their geography, background, or where they receive care. I am sincerely grateful to the conference organizers and Magnus Group for the kind invitation and the opportunity to contribute to this important global dialogue. A very special thank you to Dr. Arturo Loaiza-Bonilla, whose exceptional mentorship, unwavering support, and visionary leadership continue to inspire me. Your guidance has been instrumental in advancing our research, opening doors to new opportunities, and challenging us to think bigger about what we can accomplish for our patients. I am truly fortunate to have you as a mentor, collaborator, and friend. Scientific progress is never the achievement of one individual. It is the product of dedicated teams, extraordinary mentors, and a shared belief that we can—and must—do better for our patients. The future of medicine will not be defined by technology alone, but by our ability to translate innovation into meaningful improvements in human lives. Grateful for the opportunity to share our work on the global stage and excited for what lies ahead! #WALC2026 #ArtificialIntelligence #CellTherapy #GeneTherapy #PrecisionOncology #ClinicalTrials #CancerResearch #MedicalInnovation #GlobalOncology #Mentorship @magnus_group @DrArturoAI

What good is a breakthrough in cancer care if the patients who need it most never have the opportunity to benefit from it? This was one of the central questions I had the opportunity to explore at the Multi-Institutional Prostate Cancer Symposium in New York City. It was a wonderful evening of meaningful conversations, new connections, and shared perspectives on the future of oncology. During my presentation, Closing the Prostate Cancer Equity Gap, I shared our journey with MedNews Week—an initiative that began with a simple belief: access to medical knowledge should never be determined by geography, financial resources, or circumstance. What started as an idea has grown into a global educational community reaching clinicians, researchers, trainees, and patient advocates across more than 150 countries. We also explored how emerging technologies, particularly AI-enabled clinical trial matching, may help address another persistent challenge in oncology: connecting patients with potentially life-changing clinical trials. But perhaps my favorite part of the evening wasn't the presentation itself. It was the conversations that followed—the exchange of ideas, different perspectives, and the reminder that some of the most meaningful progress begins when people come together around a shared purpose. It was a pleasure sharing the program with Dr. Aaron Holmes, who delivered an insightful discussion on radionuclide therapy in prostate cancer. A heartfelt thank you to the Cancer Support Community Greater NY & CT for the invitation and for bringing together such a wonderful group of individuals committed to improving cancer care. Because ultimately, the true measure of medical progress isn't simply what we discover. It's who we are able to reach. #ProstateCancer #Oncology #MedNewsWeek #GlobalHealth #HealthEquity #CancerResearch #ClinicalTrials #MedicalEducation

Energized after an incredible SHIFT 2026: Driving Innovations in Oncology! Really enjoyed the conversations around AI implementation in oncology, overcoming barriers to adoption, and emerging applications across cellular therapy and precision cancer care. Outstanding speakers, engaging panels, and meaningful discussions about how we translate innovation into real impact for our patients. A special thank you to Dr. Flora and Dr. Juneja for the invitation and to the entire TensorBlack team for bringing together such a dynamic community. It was especially meaningful to represent MedNews Week alongside Dr. Park reconnect with colleagues, and exchange ideas with so many leaders across oncology. Grateful for the conversations, new ideas, and connections—and already looking forward to SHIFT 2027! 🚀 #SHIFT2026 #AIinOncology #Oncology #CellTherapy #ArtificialIntelligence #Innovation